MS Patients Can Tolerate Exercise According to University of Vermont Study
A new study conducted at the Department of Rehabilitation and Movement Science of the University of Vermont, reinforces the idea…
Articles by Patricia Silva, PhD
Kessler Study Recommends Wellness Program for Multiple Sclerosis
In today’s healthcare environment, it is often not enough that patients are provided with the latest treatments. Good health…
Continuing Multiple Sclerosis Education To Be Offered at AIMS Live Meetings
With multiple sclerosis (MS) prevalence rates still at concerning levels of 90 for every 100,000 Americans, researchers are continuously…
Evotec Multiple Sclerosis Drug Studies Receive €5 Million in New Funding
Funding for continued research and development into understanding, treating, and eventually curing Multiple Sclerosis continues to accelerate. Evotec AG,…
Multiple Sclerosis Summit in Quebec to Feature “Deepelling” As Encouragement for Active MS Lifestyles
Deepelling International conferences on multiple sclerosis (MS) typically gather the most accomplished experts and leading biotech companies under one…
Researchers Reveal Relevance of Microparticle Levels in MS, Clinically Isolated Syndrome
Researchers are continuing to make headway in discovering new insights into how MS works, which in turn could lead…
Women with Disabilities Like Multiple Sclerosis Photographed for The Raw Beauty Project NYC
Joy Nabors – The Raw Beauty Project NYC model living with Multiple Sclerosis In a bold movement aimed towards…
Accelerated Cure Project for MS, EMD Serono To Study Treatment Outcomes
The nonprofit organization Accelerated Cure Project for Multiple Sclerosis is going to sponsor the launch of the Optimizing Treatment –…
MuckFest MS Los Angeles 5K Mud Fun Run on October 25
MuckFest® MS runners getting down and dirty for a cause. One of the more engaging ways to campaign for…
Fatigue Felt by MS Patients May Be From Underdiagnosed Sleep Disorders
The underlying cause of fatigue experienced by multiple sclerosis (MS) patients may be undiagnosed sleep disorders, according to a study…
Biogen’s Two-Year Study Confirms Plegridy’s Efficacy and Safety as Relapsing MS Treatment
Biogen Idec revealed data from its second year of the phase 3 ADVANCE clinical trial for the study…
Merck Serono Awards €1 Million at the Second Annual Grant for Multiple Sclerosis Innovation
Biopharmaceutical company Merck Serono, a division of Merck, recently awarded a total of €1 million to the five winners of the second…
Teva, Active Biotech Present Positive Findings for RRMS Experimental Therapy Laquinimod
During the 30th Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) last week in…
Biogen Idec’s Study Reviews Positive Results Over Five Years of Tecfidera RRMS Treatment
Biogen Idec presented the five-year results from its ENDORSE phase 3 extension study of Tecfidera (dimethyl fumarate), which revealed…
Novartis Presents Impressive Gilenya Updates at MSBoston 2014
This past Wednesday, September 10th, the largest, most anticipated multiple sclerosis (MS) convention — the 6th Joint ACTRIMS-ECTRIMS Triennial…
EMD Serono’s Multiple Sclerosis Pipeline On Display at 2014 ACTRIMS-ECTRIMS Meeting in Boston
During the joint meeting of the Americas Committee for Treatment and Research in MS (ACTRIMS) and European Committee…
Receptos to Present Data on RMS Treatment Trial at MSBoston 2014
Biopharmaceutical company Receptos, Inc. announced that they will review data from the phase 2 portion of the …
Multiple Sclerosis Trial for Lisinopril Granted $1.4 Million in New Funding From NCATS
Transparency Life Sciences, LLC (TLS), the first clinical-stage drug development company based on open innovation in the world, recently received a $1.4 million Small…
MS Diagnosis Inspires Miss Kentucky For 2015 Miss America Pageant
For a 23 year-old country girl from the University of Kentucky to go through the harsh demands of an American…
Largest Multiple Sclerosis Conference Begins in Boston; 8,000 Attendees Expected
See below for the complete schedule for this year’s ACTRIMS-ECTRIMS Multiple Sclerosis conference in Boston, and stay tuned to Multiple…
Genzyme’s Aubagio, Lemtrada MS Therapies To Showcase at Conference
During the 30th Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) taking place in Boston…
Large Multiple Sclerosis Product Update To Be Presented By Biogen
Biogen Idec, one of the first true biotech companies specializing in products indicated for neurodegenerative diseases, hematologic conditions, and autoimmune…
Novartis to Present New Gilenya Data at ACTRIMS-ECTRIMS Meeting
Those attending this week’s ACTRIMS-ECTRIMS convention set to take place on the 10th of September until the 13th…
Future MS Therapies Could Target, Treat Intestinal Barrier
A new study, entitled, “Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and…
Walking Speed in MS Patients May Indicate Worsening of Disease
A dynamic research team composed of doctors and scientists recently completed and published a study that sought to gain a…
Autoimmune Diseases Like MS Can Be “Switched Off,” According To Bristol Scientists
Researchers from the University of Bristol have found a way of convert the function of cells into protecting the…
Importance of Brain Shrinkage for MS Treatment Measure Focus of Novartis Presentation
Novartis has announced that it will present new analyses and redefined treatment goals for multiple sclerosis (MS) at the …
Researchers Advance New Stem Cell Methods for Remyelination in MS Patients
In-vitro laboratory experiments using stem cells have long-since been the subject of debate between scientists and naturalists, but when…
Mylan’s Generic Copaxone Injection ANDA Approved for Filling by the FDA
The U.S. Food and Drug Administration (FDA) accepted the abbreviated new drug application…
Yoga Can Improve MS Patients’ Quality of Life According to Rutgers’ Researchers
Yoga improves the quality of life of patients who suffer from multiple sclerosis, as recently concluded during a study of…